Nothing Special   »   [go: up one dir, main page]

GB201121233D0 - Modified proteins and peptides - Google Patents

Modified proteins and peptides

Info

Publication number
GB201121233D0
GB201121233D0 GBGB1121233.9A GB201121233A GB201121233D0 GB 201121233 D0 GB201121233 D0 GB 201121233D0 GB 201121233 A GB201121233 A GB 201121233A GB 201121233 D0 GB201121233 D0 GB 201121233D0
Authority
GB
United Kingdom
Prior art keywords
peptides
modified proteins
proteins
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1121233.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB1121233.9A priority Critical patent/GB201121233D0/en
Publication of GB201121233D0 publication Critical patent/GB201121233D0/en
Priority to CN201280051150.4A priority patent/CN103917557B/en
Priority to MX2014001883A priority patent/MX2014001883A/en
Priority to CN201810128962.3A priority patent/CN108178800B/en
Priority to TW101129262A priority patent/TW201321405A/en
Priority to AU2012296961A priority patent/AU2012296961B2/en
Priority to UAA201401344A priority patent/UA118833C2/en
Priority to KR1020197027997A priority patent/KR102143506B1/en
Priority to EP17191815.4A priority patent/EP3339322A3/en
Priority to EA201490262A priority patent/EA027160B1/en
Priority to JP2014525418A priority patent/JP6297976B2/en
Priority to NZ621203A priority patent/NZ621203B2/en
Priority to KR1020147006909A priority patent/KR102162413B1/en
Priority to US14/239,196 priority patent/US10808040B2/en
Priority to ARP120102955A priority patent/AR087521A1/en
Priority to SG2014010482A priority patent/SG2014010482A/en
Priority to SG10201605891TA priority patent/SG10201605891TA/en
Priority to PCT/EP2012/065782 priority patent/WO2013024059A2/en
Priority to MYPI2014700336A priority patent/MY167125A/en
Priority to UY0001034254A priority patent/UY34254A/en
Priority to BR112014003679-9A priority patent/BR112014003679B1/en
Priority to EP15180982.9A priority patent/EP2987806A3/en
Priority to PE2014000214A priority patent/PE20141522A1/en
Priority to ES12746095T priority patent/ES2813432T3/en
Priority to CA2845029A priority patent/CA2845029A1/en
Priority to EP12746095.4A priority patent/EP2744822B1/en
Priority to IL230918A priority patent/IL230918A0/en
Priority to CO14029997A priority patent/CO7020851A2/en
Priority to CL2014000381A priority patent/CL2014000381A1/en
Priority to CR20140077A priority patent/CR20140077A/en
Priority to DO2014000029A priority patent/DOP2014000029A/en
Priority to MA36807A priority patent/MA35428B1/en
Priority to HK16102229.1A priority patent/HK1214281A1/en
Priority to AU2016277685A priority patent/AU2016277685B2/en
Priority to JP2018029267A priority patent/JP2018117623A/en
Priority to AU2019201505A priority patent/AU2019201505A1/en
Priority to JP2019222041A priority patent/JP6979446B2/en
Priority to US17/014,441 priority patent/US20210017293A1/en
Ceased legal-status Critical Current

Links

GBGB1121233.9A 2011-08-17 2011-12-12 Modified proteins and peptides Ceased GB201121233D0 (en)

Priority Applications (38)

Application Number Priority Date Filing Date Title
GBGB1121233.9A GB201121233D0 (en) 2011-12-12 2011-12-12 Modified proteins and peptides
MX2014001883A MX2014001883A (en) 2011-08-17 2012-08-13 Modified proteins and peptides.
MYPI2014700336A MY167125A (en) 2011-08-17 2012-08-13 Modified proteins and peptides
BR112014003679-9A BR112014003679B1 (en) 2011-08-17 2012-08-13 SINGLE IMMUNOGLOBULIN VARIABLE DOMAIN, PHARMACEUTICAL COMPOSITION, FORMULATION, ISOLATED OR RECOMBINANT NUCLEIC ACID, VECTOR, TRANSGENIC MICROORGANISM, AND, USE OF A PHARMACEUTICAL COMPOSITION
CN201810128962.3A CN108178800B (en) 2011-08-17 2012-08-13 Modified single variable domain antibodies with reduced binding to anti-drug antibodies
TW101129262A TW201321405A (en) 2011-08-17 2012-08-13 Modified proteins and peptides
AU2012296961A AU2012296961B2 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
UAA201401344A UA118833C2 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
KR1020197027997A KR102143506B1 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
EP17191815.4A EP3339322A3 (en) 2011-08-17 2012-08-13 Immunoglobulin single variable domain antibodies with a c-terminal extension for reduced immunogenicity
UY0001034254A UY34254A (en) 2011-08-17 2012-08-13 PROTEINS AND MODIFIED PEPTIDES.
JP2014525418A JP6297976B2 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
NZ621203A NZ621203B2 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
KR1020147006909A KR102162413B1 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
US14/239,196 US10808040B2 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
ARP120102955A AR087521A1 (en) 2011-08-17 2012-08-13 PROTEINS AND MODIFIED PEPTIDES
SG2014010482A SG2014010482A (en) 2011-08-17 2012-08-13 Modified proteins and peptides
SG10201605891TA SG10201605891TA (en) 2011-08-17 2012-08-13 Modified proteins and peptides
PCT/EP2012/065782 WO2013024059A2 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
CN201280051150.4A CN103917557B (en) 2011-08-17 2012-08-13 The single variable domains antibody through modification combined with anti-drug antibodies with reduction
EA201490262A EA027160B1 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
EP15180982.9A EP2987806A3 (en) 2011-08-17 2012-08-13 Modified single variable domain antibodies with reduced binding to anti-drug-antibodies
EP12746095.4A EP2744822B1 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
PE2014000214A PE20141522A1 (en) 2011-08-17 2012-08-13 PROTEINS AND MODIFIED PEPTIDES
ES12746095T ES2813432T3 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
CA2845029A CA2845029A1 (en) 2011-08-17 2012-08-13 Modified proteins and peptides
IL230918A IL230918A0 (en) 2011-08-17 2014-02-11 Modified proteins and peptides
CO14029997A CO7020851A2 (en) 2011-08-17 2014-02-12 Proteins and modified peptides
CL2014000381A CL2014000381A1 (en) 2011-08-17 2014-02-14 Single immunoglobulin variable domain; pharmaceutical composition comprising said domain; use of said domain to treat or prevent acute lung injury or acute insufficiency syndrome.
CR20140077A CR20140077A (en) 2011-08-17 2014-02-17 PROTEINS AND MODIFIED PEPTIDES
DO2014000029A DOP2014000029A (en) 2011-08-17 2014-02-17 PROTEINS AND MODIFIED PEPTIDES.
MA36807A MA35428B1 (en) 2011-08-17 2014-03-06 Proteins and peptides podified
HK16102229.1A HK1214281A1 (en) 2011-08-17 2014-06-26 Modified single variable domain antibodies with reduced binding to anti-drug-antibodies
AU2016277685A AU2016277685B2 (en) 2011-08-17 2016-12-22 Modified proteins and peptides
JP2018029267A JP2018117623A (en) 2011-08-17 2018-02-22 Modified proteins and peptides
AU2019201505A AU2019201505A1 (en) 2011-08-17 2019-03-05 Modified proteins and peptides
JP2019222041A JP6979446B2 (en) 2011-08-17 2019-12-09 Modified proteins and peptides
US17/014,441 US20210017293A1 (en) 2011-08-17 2020-09-08 Modified proteins and peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1121233.9A GB201121233D0 (en) 2011-12-12 2011-12-12 Modified proteins and peptides

Publications (1)

Publication Number Publication Date
GB201121233D0 true GB201121233D0 (en) 2012-01-18

Family

ID=45541513

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1121233.9A Ceased GB201121233D0 (en) 2011-08-17 2011-12-12 Modified proteins and peptides

Country Status (1)

Country Link
GB (1) GB201121233D0 (en)

Similar Documents

Publication Publication Date Title
IL260045B (en) Polypeptide constructs and uses thereof
IL230918A0 (en) Modified proteins and peptides
HK1200871A1 (en) Modified dna-binding proteins and uses thereof dna-
HK1199892A1 (en) Modified mini-hepcidin peptides and methods of using thereof
IL279676A (en) Recombinant proteins and their therapeutic uses
IL222961A0 (en) Novel dna-dinding proteins and uses thereof
EP2593469A4 (en) Modified polypeptides and proteins and uses thereof
EP2900697A4 (en) Peptide directed protein knockdown
ZA201400562B (en) Axmi205 variant proteins and methods for their use
EP2738255A4 (en) Erap1-derived peptide and use thereof
SG11201500111VA (en) Peptides and uses thereof
HK1198832A1 (en) Fn14 binding proteins and uses thereof fn14
EP2711376A4 (en) Fgfr-fc fusion protein and use thereof
EP2793921A4 (en) Saposin-a derived peptides and uses thereof
EP2742153A4 (en) Protein and peptide libraries
EP2825548A4 (en) Modified kisspeptin peptides and uses thereof
EP2598636A4 (en) Vectors and methods for recombinant protein expression
EP2740740A4 (en) Edar ligand-derived peptide and uses thereof
EP2762149A4 (en) Erythropoietin-derived peptide and use therefor
EP2771689A4 (en) Usp2a peptides and antibodies
GB201121233D0 (en) Modified proteins and peptides
GB201121226D0 (en) Modified proteins and peptides
GB201121236D0 (en) Proteins and peptides
GB201214769D0 (en) Methodsa and peptides
HUP1100282A2 (en) Protein factor

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)